Funding
← Back to your selection

Modi Ventures

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
4
Confirmed lead rounds
0
3 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$313.5M
4 disclosed · full round size, not this investor’s share

By stage

Series A2
Series B1
Undisclosed1

By primary sector

Biotech4

By country

United States2
Denmark1
Germany1

Rounds

4 in this selection
Latus Bio, Inc.

Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2

$97MSeries A
Role not disclosed
Exciva

Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease

€51MSeries B
Role not disclosed
Proxima

Develops AI-driven drug discovery for proximity therapeutics

$80MUndisclosed
Role not disclosed